A new study reported that SARS-CoV-2, the virus that causes COVID, can infect dopamine neurons in the brain and trigger senescence—when a cell loses the ability to grow and divide. The researchers from Weill Cornell Medicine, ...
Jan 17, 2024
0
72
Studying strange forms of RNA associated with the formation of aggregates in the brains of ALS patients could lead to new avenues for treatments.
Dec 18, 2023
0
40
Experts today call for more value to be given to patients' "lived experiences" as a study of over 1,000 patients and clinicians found multiple examples of patient reports being under-valued.
Dec 17, 2023
3
64
While previous studies suggest Parkinson's disease begins in the gut and spreads to the brain, how the process occurs has been elusive. Now, a pre-clinical study led by Duke Health researchers provides new evidence that bolsters ...
Dec 12, 2023
0
158
Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular ...
Nov 13, 2023
0
99
The emergence of different variants of SARS-CoV-2 has produced a wide range of clinical profiles and symptoms in patients. For the first time, researchers at the Institut Pasteur and Université Paris Cité have demonstrated, ...
Oct 27, 2023
0
72
The human gut microbiome has a significant impact on our health. Research has shown that it can influence the development and response of emotions, but the relationship between post-traumatic stress disorder (PTSD) and the ...
Oct 19, 2023
0
313
In a major step toward untangling the genetic complexities of rare diseases, KAUST researchers have unveiled an innovative AI-based tool that leverages varied symptom descriptions, along with evidence from the scientific ...
Oct 10, 2023
0
10
Long COVID patients have clear differences in immune and hormone function to patients without the condition, according to a new study led by the Icahn School of Medicine at Mount Sinai and Yale School of Medicine.
Sep 25, 2023
0
80
A research group at the University of Helsinki and its partners have found a promising drug candidate for the treatment of amyotrophic lateral sclerosis (ALS). Cerebral dopamine neurotrophic factor CDNF prolongs the lifespan ...
Sep 22, 2023
0
23
